1 |
American Cancer Society.Global cancer facts&figures 2007.2007,12.
|
2 |
Pawlik TM,Choti MA.Surgical therapy for colorectal metastases to the liver.J Gastrointest Surg,2007,11(8):1057-1077.
|
3 |
Catell RB.Successful removal of liver metastasis from a carcinoma of the rectum.Lahey Clinic Bull,1940,2:7-10.
|
4 |
李玉明,詹文华,韩方海,等.大肠癌同时性肝转移外科治疗的预后因素分析.中华普通外科杂志,2005,20:625-628.
|
5 |
Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg, 2006,141(10):1006-1012;discussion 1013.
|
6 |
Sugawara Y,Yamamoto J,Yamasaki S,et al.Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy.Surgery,2001,129(4):408-413.
|
7 |
Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.Ann Surg,2005,241(5):715-722.
|
8 |
Bockhorn M,Frilling A,Frühauf NR,et al.Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?J Gastrointest Surg,2008,12(8):1399-1405.
|
9 |
Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.J Magn Reson Imaging,1997,7(6):1040-1047.
|
10 |
Kong G, Jackson C, Koh DM, et al. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging,2008,35(7):1323-1329.
|
11 |
Lubezky N, Metser U, Geva R, et al. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography(CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.J Gastrointest Surg,2007,11(4):472-478.
|
12 |
Nordlinger B,Jaeck D.Treatment of hepatic metastases of colorectal cancer.Paris:Springer-Verlag,1992:129-146.
|
13 |
Weber JC,Bachellier P,Oussoultzoglou E,et al.Colorectal primary tumour and synchronous liver metastases.Br J Surg,2003,90(8):956-962.
|
14 |
Xu J,Wei Y,Zhong Y,et al.Hepatectomy for liver metastasis of colorectal cancer.Int J Colorectal Dis,2008,19.
|
15 |
Allen PJ,Kemeny N,Jarnagin W,et al.Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.J Gastrointest Surg,2003,7(1):109-115.
|
16 |
Nordlinger B,Sorbye H,Glimelius B,et al.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC Intergroup trial 40983):a randomised controlled trial.Lancet,2008,371(9617):1007-1016.
|
17 |
Tsai MS,Su YH,Ho MC,et al.Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol,2007,14(2):786-794.
|
18 |
Bismuth H,Adam R,LéviF,et al.Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg, 1996,224(4):509-520.
|
19 |
Nuzzo G, Giuliante F, Ardito F, et al. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy. J Gastrointest Surg,2007,11(3):318-324.
|
20 |
Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.Ann Surg,2000,231(4):480-486.
|